Based on the results of a readership survey of educational need, Kathy S. Albain, MD; Kathy D. Miller, MD; Hope S. Rugo, MD; and Linda T. Vahdat, MD, discuss breast cancer cases and optimal treatment regimens for patients in the adjuvant, neoadjuvant, and metastatic settings.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain treatment options for patients with HER2-positive breast cancer
- Discuss the prognosis of patients with node-negative vs node-positive breast cancer
- Identify treatment options for patients with breast cancer who have progressed on trastuzumab and chemotherapy
- Describe the use of adjuvant therapy for HER2-positive metastatic breast cancer
- Summarize outcomes seen with various preoperative regimens for patients with HER2-positive breast cancer